• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超越癌细胞:肿瘤微环境如何推动癌症进展。

Beyond Cancer Cells: How the Tumor Microenvironment Drives Cancer Progression.

机构信息

Department of Medical Biotechnology, College of Biotechnology, Misr University for Science and Technology, Giza P.O. Box 77, Egypt.

Institute of Laboratory Medicine and Pathobiochemistry, Molecular Diagnostics, Hospital of the Universities of Giessen and Marburg (UKGM), Philipps University Marburg, Baldinger Str., 35043 Marburg, Germany.

出版信息

Cells. 2024 Oct 9;13(19):1666. doi: 10.3390/cells13191666.

DOI:10.3390/cells13191666
PMID:39404428
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11475877/
Abstract

Liver cancer represents a substantial global health challenge, contributing significantly to worldwide morbidity and mortality. It has long been understood that tumors are not composed solely of cancerous cells, but also include a variety of normal cells within their structure. These tumor-associated normal cells encompass vascular endothelial cells, fibroblasts, and various inflammatory cells, including neutrophils, monocytes, macrophages, mast cells, eosinophils, and lymphocytes. Additionally, tumor cells engage in complex interactions with stromal cells and elements of the extracellular matrix (ECM). Initially, the components of what is now known as the tumor microenvironment (TME) were thought to be passive bystanders in the processes of tumor proliferation and local invasion. However, recent research has significantly advanced our understanding of the TME's active role in tumor growth and metastasis. Tumor progression is now known to be driven by an intricate imbalance of positive and negative regulatory signals, primarily influenced by specific growth factors produced by both inflammatory and neoplastic cells. This review article explores the latest developments and future directions in understanding how the TME modulates liver cancer, with the aim of informing the design of novel therapies that target critical components of the TME.

摘要

肝癌是一个全球性的健康挑战,对全球的发病率和死亡率有重大影响。长期以来,人们已经认识到肿瘤不仅仅由癌细胞组成,还包括其结构内的各种正常细胞。这些肿瘤相关的正常细胞包括血管内皮细胞、成纤维细胞以及各种炎症细胞,如中性粒细胞、单核细胞、巨噬细胞、肥大细胞、嗜酸性粒细胞和淋巴细胞。此外,肿瘤细胞与基质细胞和细胞外基质(ECM)的成分之间也存在着复杂的相互作用。最初,现在被称为肿瘤微环境(TME)的组成部分被认为是肿瘤增殖和局部浸润过程中的被动旁观者。然而,最近的研究极大地提高了我们对 TME 在肿瘤生长和转移中积极作用的理解。现在已知肿瘤的进展是由正、负调节信号的复杂失衡所驱动的,这些信号主要受到炎症和肿瘤细胞产生的特定生长因子的影响。这篇综述文章探讨了理解肿瘤微环境如何调节肝癌的最新进展和未来方向,旨在为靶向肿瘤微环境关键成分的新型治疗方法的设计提供信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/256b/11475877/f2dd8bcd8b6b/cells-13-01666-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/256b/11475877/5819f7308e34/cells-13-01666-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/256b/11475877/f025d1e01cf4/cells-13-01666-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/256b/11475877/f2dd8bcd8b6b/cells-13-01666-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/256b/11475877/5819f7308e34/cells-13-01666-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/256b/11475877/f025d1e01cf4/cells-13-01666-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/256b/11475877/f2dd8bcd8b6b/cells-13-01666-g003.jpg

相似文献

1
Beyond Cancer Cells: How the Tumor Microenvironment Drives Cancer Progression.超越癌细胞:肿瘤微环境如何推动癌症进展。
Cells. 2024 Oct 9;13(19):1666. doi: 10.3390/cells13191666.
2
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition.利用肿瘤微环境:通过调节上皮-间质转化实现靶向癌症治疗
J Hematol Oncol. 2025 Jan 13;18(1):6. doi: 10.1186/s13045-024-01634-6.
3
Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.全面剖析癌症生物学:解析肿瘤微环境,以实现肿瘤学临床的有效癌症治疗。
OMICS. 2020 Apr;24(4):175-179. doi: 10.1089/omi.2020.0019. Epub 2020 Mar 13.
4
The tumor microenvironment: shaping cancer progression and treatment response.肿瘤微环境:塑造癌症进展与治疗反应
J Chemother. 2025 Feb;37(1):15-44. doi: 10.1080/1120009X.2023.2300224. Epub 2024 Jan 5.
5
Significance of the Tumor Microenvironment in Liver Cancer Progression.肿瘤微环境在肝癌进展中的意义。
Crit Rev Oncog. 2020;25(1):1-9. doi: 10.1615/CritRevOncog.2020034987.
6
Tumor microenvironment: recent advances in understanding and its role in modulating cancer therapies.肿瘤微环境:理解方面的最新进展及其在调节癌症治疗中的作用
Med Oncol. 2025 Mar 18;42(4):117. doi: 10.1007/s12032-025-02641-4.
7
Extracellular matrix proteins in metastases to the liver - Composition, function and potential applications.转移到肝脏的细胞外基质蛋白 - 组成、功能和潜在应用。
Semin Cancer Biol. 2021 Jun;71:134-142. doi: 10.1016/j.semcancer.2020.06.004. Epub 2020 Jun 8.
8
Mouse Models to Evaluate the Functional Role of the Tumor Microenvironment in Cancer Progression and Therapy Responses.评估肿瘤微环境在癌症进展和治疗反应中的功能作用的小鼠模型。
Cold Spring Harb Perspect Med. 2024 Jul 1;14(7):a041411. doi: 10.1101/cshperspect.a041411.
9
Role and value of the tumor microenvironment in the progression and treatment resistance of gastric cancer (Review).肿瘤微环境在胃癌进展和治疗抵抗中的作用和价值(综述)。
Oncol Rep. 2025 Jan;53(1). doi: 10.3892/or.2024.8847. Epub 2024 Nov 29.
10
Tumor microenvironment as a complex milieu driving cancer progression: a mini review.肿瘤微环境作为驱动癌症进展的复杂环境:一篇综述短文
Clin Transl Oncol. 2025 May;27(5):1943-1952. doi: 10.1007/s12094-024-03697-w. Epub 2024 Sep 28.

引用本文的文献

1
TRP channels and cancer modulation: a voyage beyond metabolic reprogramming, oxidative stress and the advent of nanotechnologies in targeted therapy.瞬时受体电位通道与癌症调控:超越代谢重编程、氧化应激以及靶向治疗中纳米技术出现的探索之旅。
J Exp Clin Cancer Res. 2025 Aug 14;44(1):240. doi: 10.1186/s13046-025-03495-4.
2
AKR1B10 as a novel prognostic biomarker linking methylation and immune escape in hepatocellular carcinoma.AKR1B10作为一种将甲基化与肝细胞癌免疫逃逸联系起来的新型预后生物标志物。
Discov Oncol. 2025 Aug 14;16(1):1551. doi: 10.1007/s12672-025-03017-w.
3
Promoting Immune Response of Human Vascular Endothelial Cells by Bevacizumab: Insights into the Immune Supportive Role of Anti-VEGF Therapy.

本文引用的文献

1
Medical Biology of Cancer-Associated Fibroblasts in Pancreatic Cancer.胰腺癌中癌症相关成纤维细胞的医学生物学
Biology (Basel). 2023 Jul 25;12(8):1044. doi: 10.3390/biology12081044.
2
Cancer-associated fibroblast classification in single-cell and spatial proteomics data.单细胞和空间蛋白质组学数据中的癌症相关成纤维细胞分类。
Nat Commun. 2023 Jul 18;14(1):4294. doi: 10.1038/s41467-023-39762-1.
3
Reprogramming of the tumor microenvironment using a PCN-224@IrNCs/D-Arg nanoplatform for the synergistic PDT, NO, and radiosensitization therapy of breast cancer and improving anti-tumor immunity.
贝伐单抗对人血管内皮细胞免疫反应的促进作用:抗VEGF治疗免疫支持作用的见解
Int J Mol Sci. 2025 Jun 29;26(13):6280. doi: 10.3390/ijms26136280.
4
Overcoming Barriers in Cancer Biology Research: Current Limitations and Solutions.克服癌症生物学研究中的障碍:当前的局限性与解决方案
Cancers (Basel). 2025 Jun 23;17(13):2102. doi: 10.3390/cancers17132102.
5
Auranofin, an antirheumatic drug, shows anticancer stem cell potential via suppression of the Stat3 signal.金诺芬,一种抗风湿药物,通过抑制Stat3信号显示出抗癌干细胞的潜力。
BMB Rep. 2025 Jul;58(7):293-299.
6
Analysis of a pan-cancer panel reveals the amino acid metabolism-related gene MTHFD1 as a potential prognostic and immunotherapeutic biomarker.一项泛癌研究分析显示,氨基酸代谢相关基因MTHFD1是一种潜在的预后和免疫治疗生物标志物。
Exp Ther Med. 2025 May 20;30(1):142. doi: 10.3892/etm.2025.12892. eCollection 2025 Jul.
7
UBC4: A Repurposed Drug Regimen for Adjunctive Use During Bladder Cancer Treatment.UBC4:一种用于膀胱癌治疗辅助用药的重新调整的药物方案。
Biomedicines. 2025 Mar 13;13(3):706. doi: 10.3390/biomedicines13030706.
8
Comprehensive pan-cancer analysis of LAMA3: implications for prognosis and immunotherapy.层粘连蛋白α3(LAMA3)的全癌综合分析:对预后和免疫治疗的意义
Am J Transl Res. 2025 Feb 15;17(2):1200-1222. doi: 10.62347/QYJW2277. eCollection 2025.
9
Integrative bioinformatics analysis of high-throughput sequencing and in vitro functional analysis leads to uncovering key hub genes in esophageal squamous cell carcinoma.高通量测序的整合生物信息学分析与体外功能分析有助于揭示食管鳞状细胞癌中的关键枢纽基因。
Hereditas. 2025 Mar 14;162(1):38. doi: 10.1186/s41065-025-00398-4.
10
Advances in Therapy for Urothelial and Non-Urothelial Subtype Histologies of Advanced Bladder Cancer: From Etiology to Current Development.晚期膀胱癌尿路上皮和非尿路上皮亚型组织学的治疗进展:从病因到当前发展
Biomedicines. 2025 Jan 1;13(1):86. doi: 10.3390/biomedicines13010086.
利用 PCN-224@IrNCs/D-Arg 纳米平台重塑肿瘤微环境,协同光动力治疗、NO 供体治疗和放射增敏治疗乳腺癌,并增强抗肿瘤免疫。
Nanoscale. 2023 Jun 30;15(25):10715-10729. doi: 10.1039/d3nr01050c.
4
Dendritic cell subsets in cancer immunity and tumor antigen sensing.树突状细胞亚群在癌症免疫和肿瘤抗原识别中的作用。
Cell Mol Immunol. 2023 May;20(5):432-447. doi: 10.1038/s41423-023-00990-6. Epub 2023 Mar 22.
5
In situ expansion and reprogramming of Kupffer cells elicit potent tumoricidal immunity against liver metastasis.原位扩增和重编程枯否细胞引发针对肝转移的强大肿瘤杀伤免疫。
J Clin Invest. 2023 Apr 17;133(8):e157937. doi: 10.1172/JCI157937.
6
NK cells are never alone: crosstalk and communication in tumour microenvironments.自然杀伤细胞从不孤单:肿瘤微环境中的串扰和通讯。
Mol Cancer. 2023 Feb 16;22(1):34. doi: 10.1186/s12943-023-01737-7.
7
Reprogramming the tumor microenvironment with biotechnology.利用生物技术对肿瘤微环境进行重编程。
Biomater Res. 2023 Jan 31;27(1):5. doi: 10.1186/s40824-023-00343-4.
8
Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and Cholangiocarcinoma.肝癌和胆管癌中的癌相关成纤维细胞。
Cell Mol Gastroenterol Hepatol. 2023;15(4):985-999. doi: 10.1016/j.jcmgh.2023.01.006. Epub 2023 Jan 25.
9
Remodeling tumor microenvironment with natural products to overcome drug resistance.利用天然产物重塑肿瘤微环境以克服耐药性。
Front Immunol. 2022 Nov 10;13:1051998. doi: 10.3389/fimmu.2022.1051998. eCollection 2022.
10
Tumor acidity: From hallmark of cancer to target of treatment.肿瘤酸度:从癌症标志到治疗靶点
Front Oncol. 2022 Aug 29;12:979154. doi: 10.3389/fonc.2022.979154. eCollection 2022.